Drug-Induced Liver Injury Associated with the Use of Everolimus in a Liver Transplant Patient

Drug-induced liver injury (DILI) has not been previously reported as a complication of treatment with everolimus. A 56-year-old Caucasian male liver transplant recipient developed DILI after receiving everolimus. Elevations in transaminase levels occurred within a week of starting everolimus and an...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Serena, Mendler, Michel H., Valasek, Mark A., Tsunoda, Shirley M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076919/
https://www.ncbi.nlm.nih.gov/pubmed/30105113
http://dx.doi.org/10.1155/2018/7410508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6076919/
https://www.ncbi.nlm.nih.gov/pubmed/30105113
http://dx.doi.org/10.1155/2018/7410508

Ejemplares similares